What Are the Advances in Pharmacokinetic Studies for Cancer?
Recent advances in PK studies for cancer include:
The use of biomarkers to predict and monitor drug response and resistance. Application of pharmacogenomics to tailor treatments based on individual genetic profiles. Development of more sophisticated models to simulate and predict drug behavior in the body.
